207_Combined course Presentations
Molecular “status” overcomes treatment strategy…
Favourable
Unfavourable
RTOG 9402 Cairncross JG. et al. JCO 2014;32
IDH1 wt
IDH1 mutated
EORTC 26951 Van den Bent MJ. et al. JCO 2013;31
1p/19q NON codeleted
1p/19q codeleted
…can we consider RT + PCV as standard of care ?
Made with FlippingBook